EMJ | Elevating the quality of healthcare globally

This site is intended for healthcare professionals

Continue

Latest News

All News
Diabetes
19 Sep 2026

Once-Weekly Injection Outperforms Daily Insulin in Type 2 Diabetes

Once-weekly IcoSema improved HbA1c and body weight more than daily insulin glargine in Type 2 diabetes.
Cardiology
19 Sep 2026

Deep Learning Detects Valvular Heart Disease with High Accuracy

A systematic review and meta-analysis found deep learning models achieved high sensitivity and specificity for valvular heart disease detection on echocardiography.
Gastroenterology
19 Sep 2026

Top-Down Therapy in Crohn’s Disease Linked to Improved 5-Year Outcomes

Five-year PROFILE follow-up linked early top-down therapy in Crohn’s disease with fewer surgeries, hospital admissions and stricturing or penetrating disease than step-up treatment.
Neurology
19 Sep 2026

Aneurysm Treatment Timing Fails to Show Clear Benefit

A systematic review of 11,096 records found earlier aneurysm repair reduced pretreatment rebleeding after aSAH, while evidence linking treatment timing to mortality and functional outcomes remained uncertain.
Allergy & Immunology
19 Sep 2026

T-Cell Profiles Reveal New Insights into Childhood EoE

Distinct T-cell populations were linked to disease activity and treatment response in children with EoE.
Reproductive Health
19 Sep 2026

Genetic Embryo Testing Shows No Live Birth Advantage with Donor Eggs

PGT-A did not reduce embryo transfers or time to live birth among recipients of donor oocytes.
Closeup of a person's eye with glaucoma
General Healthcare
18 Sep 2026

Air Pollution Linked to Higher Glaucoma and Cataract Risk: ESCRS 2026

Higher exposure to air pollution was associated with an increased risk of developing glaucoma and cataract.
beta-blockers, myocardial infarction, heart attack, cardiovascular disease, secondary prevention, heart failure
Cardiology
18 Sep 2026

Stopping Beta-Blockers Years After Heart Attack May Be Safe

Stopping beta-blockers years after myocardial infarction was non-inferior to continued treatment in stable patients.
COVID-19-related hospitalisations autoimmune rheumatic conditions
Rheumatology
18 Sep 2026

Booster Vaccines Cut COVID-19 Hospitalisations in Rheumatic Disease

A US cohort study of 60,980 patients found that booster COVID-19 vaccines significantly lowered hospitalisation risk in rheumatic conditions.

Latest Articles

Interactive Content

Rheumatology
7 Sep 2026

Access and Affordability: Sandoz Denosumab​▼​

Biosimilars are biological medicines with an identical amino acid sequence along with structural and functional similarity to an already…
Allergy & Immunology
4 Sep 2026

Navigating the Diagnosis of Refractory Chronic Cough

A 60-year-old White female has been referred by her PCP to the pulmonologist for “investigation and treatment of worsening…
Respiratory
28 Aug 2026

Chronic Cough Mechanism and Treatment​

Chronic cough, defined as a cough that lasts ≥8 weeks, is highly prevalent in patients with IPF. It is reported in approximately 85% of…
Respiratory
17 Jul 2026

Extracorporeal CO₂ Removal in Clinical Practice

This interactive case study allows clinicians to examine a patient with COPD presenting with an acute exacerbation…
All Interactive Content

Latest Infographics

All Infographics
Rheumatology
7 Sep 2026

Access and Affordability: Sandoz Denosumab​▼​

Biosimilars are biological medicines with an identical amino acid sequence along with structural and functional similarity to an already…
Respiratory
28 Aug 2026

Chronic Cough Mechanism and Treatment​

Chronic cough, defined as a cough that lasts ≥8 weeks, is highly prevalent in patients with IPF. It is reported in approximately 85% of…
Flagship Journal
11 Aug 2026

When Inflammation Becomes Visible: Understanding its Burden

AD is a common, chronic, immune-mediated, inflammatory skin disease. Hand involvement is present in up to 56% of patients with moderate…
Microbiology & Infectious Diseases
29 Jul 2026

Balancing speed and stewardship in AMR

In the UK, Fetcroja® (Cefiderocol) is indicated for the treatment of infections due to aerobic Gram-negative organisms in adults with…

Latest Podcasts

All Podcasts
Oncology
15 Sep 2026

Onc Now: Breaking Barriers in Cancer Immunotherapy

In this episode, Bjørn Henning Grønberg explores the evolving landscape of lung cancer care, progress and remaining challenges in…
General Healthcare
14 Sep 2026

Advancing LGBTQIA+ Healthcare

In this series, host Catherine Glass speaks with Linda Wesp about advancing LGBTQIA+ healthcare through gender-affirming care, culturally…
Hematology
8 Sep 2026

Hema Now: Reimagining Multiple Myeloma Treatment

Sagar Lonial discusses advances in multiple myeloma treatment, the evolving role of immunotherapy and minimal residual disease, unmet needs…
General Healthcare
7 Sep 2026

Intersectionality and Transgender Health

In this series, host Catherine Glass speaks with Tonia Poteat about the role of intersectionality in modern healthcare and its importance in…

Latest Videos & Webinars

All Videos & Webinars
Respiratory
18 Sep 2026

ERS Congress Wrap 2026

The European Respiratory Society (ERS) Congress 2026 took place in Barcelona, Spain, bringing together the global respiratory community to…
Allergy & Immunology
17 Sep 2026

Derek Gilroy on Resolving Inflammation, Chronic Pain, and Precision Immunology

EMJ recently spoke to Derek Gilroy, Head of Department of Experimental & Translational Medicine, University College London, UK, about his…
Microbiology & Infectious Diseases
11 Sep 2026

Improving Outcomes for Haemato-Oncology Patients

This educational video features a dynamic expert debate revisiting the important aspects of empirical versus pre-emptive antifungal…
We’ve noticed you’re accessing
from North/South America.